Side Effects
Zepbound Side Effects
Tirzepatide at obesity doses, in a population that increasingly includes people treated for sleep apnea. Which raises a question the trials answer better than most people realise: what happens to daytime function while your gut is adjusting.
The Zepbound-specific companion to The Side Effects Nobody Preps You For, and to the molecule-level piece on tirzepatide.
What is different about Zepbound
Two devices, two risk profiles. Zepbound is supplied both as single-dose pens and as vials. Pens are straightforward. Vials require you to draw the dose, and unit-versus-milligram confusion at that step is a documented source of real harm with these molecules. If you are on vials, the amount you actually drew is the single most valuable thing in your record.
The sleep apnea population changes what to watch. Zepbound carries an indication for moderate-to-severe obstructive sleep apnea in adults with obesity, on the strength of SURMOUNT-OSA. If that is why you were prescribed it, there is an overlap problem worth knowing about early.
Fatigue and daytime sleepiness are common in the first weeks of any GLP-1. They are also, obviously, the cardinal symptoms of the condition you are treating. Untangling “the drug is making me tired,” “I am not eating enough,” and “my apnea is still untreated” is genuinely difficult without a record — and in my experience the second explanation is the most common and the least suspected.
Rapid loss brings its own consequences. Tirzepatide produces the largest average weight loss in this class. Gallstone risk rises with rapid loss from any method, and hair shedding around months three to five is usually telogen effluvium driven by the rate rather than by the molecule.
No hypoglycemia complication for most. Unlike the typical Mounjaro patient, most people on Zepbound are not also taking insulin or a sulfonylurea. If you are, the same caution applies.
What to expect, and when
Very common: nausea, diarrhoea, vomiting, constipation, abdominal pain, dyspepsia, fatigue, injection-site reactions.
Dose-dependent and escalation-linked. Tirzepatide’s half-life is about 5 days, so a new dose accumulates over roughly 4 weeks before it is fully the dose you are on. Judging it at day ten is judging it early.
Constipation ends more courses than nausea does. Act early — fibre, fluid, movement, an osmotic laxative if needed.
Fatigue is usually inadequate intake. Especially relevant here, for the reason above.
The red flags
These belong on a phone, not in any plan.
- Severe, persistent abdominal pain radiating to the back, often with vomiting — possible pancreatitis. Stop and seek care.
- Right-upper-quadrant pain, fever, jaundice — possible gallbladder disease.
- Vomiting or diarrhoea you cannot keep ahead of.
- Any procedure with sedation — tell the anaesthetist, unprompted.
- On vials: any uncertainty about the dose you drew.
Managing the rest
Slow the titration. The lever that resolves the most problems, and the most under-used. No prize for reaching the top dose on schedule.
Eat for the window — smaller, lower-fat meals in the 2–3 days after the injection.
Protect protein at 1.2–1.6 g/kg/day. On the highest-efficacy drug in the class, this matters more rather than less.
Separate your variables. This is the Zepbound-specific advice. Log side effects, intake, and — if apnea is your indication — sleep and daytime sleepiness, in the same place. Three overlapping explanations for the same symptom become distinguishable only when they sit on one timeline.
That is the argument for a structured plan over a leaflet, and it is why I use one. The Zenday App builds a customised plan for minimising side effects from your own logged dose timing and symptoms, using management protocols written by its clinical team; more than a million people use it.
The reason I recommend structure specifically on this page is blunt: side effects are among the most common reasons people abandon tirzepatide, almost always in the first 3 months, and almost always while experiencing something ordinary and self-limiting that nobody prepared them for. Anticipating the difficult week beats treating it.
And the line I will not blur: it manages tolerability. It is not a substitute for your prescriber, and no red flag above should be routed through an app.
Three sentences
- If side effects are bad, the answer is usually a slower titration — call before you quit.
- Severe persistent abdominal pain, or vomiting you cannot stay ahead of, means same-day contact.
- If you are tired all the time, check what you actually ate before you conclude it is the drug.
Beyond the symptom list: agree in advance which of your other medications you hold during a dehydrating illness (sick day rules), and tell any anaesthetist you are on this drug (GLP-1s, surgery and procedures). Zepbound’s sleep apnea indication also means your CPAP settings will drift as you lose weight — GLP-1s and sleep apnea.
For orientation: tirzepatide’s half-life is about 5 days, doses start at 2.5 mg and escalate at 4 week intervals, and symptoms usually peak in the 1–2 weeks after each step. Protein wants 1.2–1.6 g/kg a day throughout.
Questions I get about this month
- What are the most common Zepbound side effects?
- Nausea, diarrhoea, vomiting, constipation, abdominal pain, dyspepsia, fatigue and injection-site reactions were the most frequently reported in the tirzepatide obesity trials. They are dose-dependent, most pronounced in the week following each dose increase, and generally settle as you stabilise. Constipation and reflux are under-discussed relative to how often they cause people to stop treatment.
- How long do Zepbound side effects last after starting?
- Most people notice effects within the first day or two after an injection, with the strongest week following each dose escalation and settling over roughly seven days. Tirzepatide's half-life is about five days, so exposure accumulates over approximately four weeks to a steady level at any given dose — which is why the standard escalation interval is four weeks, and why judging a new dose after ten days tells you very little.
- Does Zepbound cause gallbladder problems?
- Rapid weight loss from any cause increases the risk of gallstones, and there is a gallbladder signal in the GLP-1 data specifically. The practical implication is symptom awareness rather than avoidance. New right-upper-quadrant pain, particularly after fatty meals and especially accompanied by fever or jaundice, needs prompt evaluation rather than waiting for a routine appointment.
- Can Zepbound side effects be confused with sleep apnea symptoms?
- Early on they can overlap, which is worth knowing if you were prescribed Zepbound for obstructive sleep apnea. Fatigue and daytime sleepiness are common in the first weeks of treatment, and are frequently caused by inadequate intake rather than by the drug — appetite suppression means hunger stops being a reliable prompt to eat. Logging sleep and daytime sleepiness alongside intake helps separate an under-eating problem from an untreated apnea problem.
Sources
- 01FDA prescribing information, Zepbound (tirzepatide) injection.
- 02Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
- 03Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). NEJM, 2024.
- 04He L et al. Association of GLP-1 receptor agonist use with risk of gastrointestinal adverse events. JAMA, 2023.
Elise Hall, MD
Board-certified internist in Los Angeles, twenty-one years in practice. She writes about GLP-1 medications and metabolic health for people who want the reasoning, not just the conclusion — and publishes her own year on one of these drugs alongside it.
Keep reading
Supplements
The Best Supplements for GLP-1 Hair Loss
The shedding starts two to four months after the loss speeds up, which is why almost nobody connects the two. Seven supplements ranked — and one of them interferes with the blood test that rules out a heart attack.
Supplements
Best Bone Health Supplements on a GLP-1
Bone is the tissue nobody thinks about until a wrist breaks. Rapid weight loss reduces bone mineral density, the effect is largest in exactly the people most likely to be prescribed these drugs, and none of it produces a symptom until it does.
Tools
The Best GLP-1 Apps, Ranked
I scored every tracker I could get my hands on against seven criteria that matter specifically on a GLP-1 — not generic calorie counting. Here is the ranking, the rubric behind it, and where my first choice falls short.